This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tali Benromano: Innovator in Pharmaceutical Peptides
Introduction
Tali Benromano is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptides with therapeutic applications. His work focuses on addressing critical health issues such as diabetes and obesity.
Latest Patents
Tali Benromano holds a patent for "Peptides, pharmaceutical compositions comprising same and uses thereof." This patent describes the use of an isolated peptide that consists of an amino acid sequence of no more than 25 amino acids. The peptide includes at least one aspartate or a homolog thereof and exhibits Insulin-Degrading Enzyme (IDE) inhibitory activity. It is intended for the manufacture of a medicament aimed at treating various diseases, including diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage, and varicella-zoster virus (VZV) infection. He has 1 patent to his name.
Career Highlights
Tali Benromano is affiliated with Tel Aviv University, where he conducts research and develops innovative pharmaceutical solutions. His academic background and research endeavors have positioned him as a key figure in the field of peptide-based therapeutics.
Collaborations
Tali collaborates with esteemed colleagues, including Adi Kopelevich and Veronica Lifshitz, who contribute to his research initiatives and projects.
Conclusion
Tali Benromano's work in the development of pharmaceutical peptides showcases his commitment to advancing medical science. His innovative approach has the potential to significantly impact the treatment of various diseases.